The National Institute for Health and Care Excellence has turned down NHS funding for use of Novartis’ CAR-T therapy Kymriah in adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). More: NICE rejects Novartis’ CAR-T Kymriah for adult lymphoma
read moreInnovate UK is streaming funds into a £1-million artificial intelligence (AI) research project to be delivered by the Medicines Discovery Catapult and two Cambridge-based firms with expertise in software/machine learning. More: AI drug discovery platform gets £1m innovation boost Source:
read moreA new report from NHS Digital shows that a decreasing number of children are being vaccinated against potentially deadly or life-altering diseases such as tetanus, diphtheria and polio More: The number of children being vaccinated in England falls again Source:
read moreThe European Commission has approved Almirall’s Ilumetri for moderate-to-severe chronic plaque psoriasis. More: Almirall steps into psoriasis market with Ilumetri approval Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals